glp 1 sglt2 3. Integration of GLP-1RA or SGLT2i in Patients With T2D With or at Risk of atherosclerotic CVD Common systemic effects of either

A previous mediation analysis of semaglutide in adults with overweight or obesity suggested that less than one percentage point of the body weight reduction achieved with subcutaneous semaglutide was attributable to gastrointestinal adverse events (246)

Rapid Weight Loss Weight loss itself requires metabolic adaptation

To counter this limitation, a group of GLP-1 receptor agonists (GLP-1RAs), which are resistant to DPP4-mediated degradation [32], have been developed and shown to be effective in treating T2DM and obesity [33]

Protein First: Your Muscle-Saving Strategy Let's get one thing straight: protein is non-negotiable on GLP-1 medications

Most people report feeling significantly better by week 2 and have their eating routine dialed in by week 4